(2026). Correction: Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Correction: Hsa-mir-3163 and CCNB1 May Be Potential Biomarkers and Therapeutic Targets for Androgen Receptor Positive Triple-negative Breast Cancer."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Correction: Hsa-mir-3163 and CCNB1 May Be Potential Biomarkers and Therapeutic Targets for Androgen Receptor Positive Triple-negative Breast Cancer."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.